Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shenzhou Biology & Technology Co., Ltd. is a high-tech enterprise specializing in the research, development, and large-scale production of biological fermentation products. As a subsidiary of the China Aerospace Science and Technology Corporation (CASC), the company leverages aerospace bio-technology to produce high-quality active pharmaceutical ingredients (APIs) and nutritional supplements. Its core product portfolio includes Coenzyme Q10, Vitamin B12, and Lovastatin, which are distributed globally to the pharmaceutical, food, and feed industries. The company operates large-scale, GMP-compliant manufacturing facilities in Inner Mongolia, focusing on industrial-scale fermentation and purification processes. Shenzhou Biology & Technology is recognized for its integration of aerospace science with industrial biotechnology to optimize microbial strains and production yields.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shenzhou Biology & Technology.